Sutezolid

Generic Name: Sutezolid

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₁₆H_₂₀FN_₃O_₃S

CAS Number: 168828-58-8

Unique Ingredient Identifier: 3A71182L8P

Background: Sutezolid has been used in trials studying the treatment of Tuberculosis.

Associated Conditions: -

Associated Therapies: -

Clinical Trials

Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis

Phase 2

Not yet recruiting

Conditions: Pulmonary Tuberculosis

Interventions: Drug: Isoniazid
Drug: Rifampicin
Drug: Bedaquiline
Drug: Pyrazinamide
Drug: Pretomanid
Drug: Ethambutol
Drug: Linezolid
Drug: TBI-223
Drug: Sutezolid

First Posted Date: 2024-01-05

Last Posted Date: 2024-11-13

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 315

Registration Number: NCT06192160

Locations: 🇺🇬
12401, Joint Clinical Research Centre (JCRC)/Kampala CRS, Kampala, Uganda
🇲🇼
30301, Blantyre CRS, Blantyre, Malawi
🇲🇼
12001, Malawi CRS, Lilongwe, Malawi

and more 21 locations

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy